Wayne A. Marasco
54Patents
10h-index
29Co-inventors
78Inventor score
Filing activity: Dec 6, 1994 → Jun 22, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5851829A | Method of intracellular binding of target molecules | Chemistry; Metallurgy | 92 | Expired |
| US6004940A | Intracellular targeting of endogenous proteins | Chemistry; Metallurgy | 79 | Expired |
| US5965371A | Method of intracellular binding of target molecules | Chemistry; Metallurgy | 53 | Expired |
| US6329173A | Method of intracellular binding target molecules | Chemistry; Metallurgy | 51 | Expired |
| US6479284B1 | Humanized antibody and uses thereof | Chemistry; Metallurgy | 28 | Expired |
| US6830892B2 | Lentiviral vector system for high quantity screening | Chemistry; Metallurgy | 27 | Expired |
| US6072036A | Method of intracellular binding of target molecules | Chemistry; Metallurgy | 18 | Expired |
| US6143520A | Expression vectors and methods of use | Chemistry; Metallurgy | 17 | Expired |
| US5852186A | Reactive neutralizing human anti-GP120 recombinant antibody, DNA coding the same and use thereof | Human Necessities | 15 | Expired |
| US7750123B2 | Antibodies against SARS-CoV and methods of use thereof | Chemistry; Metallurgy | 12 | Active |
| US8466263B2 | Carbonic anhydrase IX (G250) anitbodies | Chemistry; Metallurgy | 10 | Active |
| US9676867B2 | Chimeric T cell receptor comprising carbonic anhydrase IX (G250) antibody | Chemistry; Metallurgy | 10 | Active |
| US8329178B2 | Antibodies against CXCR4 and methods of use thereof | Chemistry; Metallurgy | 7 | Active |
| US9828434B2 | Human monoclonal anti-PD-L1 antibodies and methods of use | Chemistry; Metallurgy | 7 | Active |
| US9527924B2 | Humanized monoclonal antibodies and methods of use | Chemistry; Metallurgy | 5 | Active |
| US7186697B2 | Nucleic acid delivery system, methods of synthesis and use thereof | Chemistry; Metallurgy | 3 | Expired |
| US8962806B2 | Humanized monoclonal antibodies and methods of use | Chemistry; Metallurgy | 2 | Active |
| US9822166B2 | Flavivirus neutralizing antibodies and methods of use thereof | Emerging Cross-Sectional Technologies | 2 | Active |
| US10131704B2 | Middle east respiratory syndrome coronavirus neutralizing antibodies and methods of use thereof | Physics | 2 | Active |
| US7262049B2 | Pseudotyped lentiviral vectors and uses thereof | Chemistry; Metallurgy | 2 | Expired |
| US10675349B2 | Humanized CC chemokine receptor 4 (CCR4) antibodies and methods of use thereof | Chemistry; Metallurgy | 2 | Active |
| US11174323B2 | Method of treating renal cancer using carbonic anhydrase IX (G250) antibodies | Chemistry; Metallurgy | 2 | Active |
| US10179822B2 | Humanized monoclonal antibodies and methods of use | Chemistry; Metallurgy | 1 | Active |
| US10400032B2 | Flavivirus neutralizing antibodies and methods of use thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US9416169B2 | Humanized monoclonal antibodies and methods of use | Chemistry; Metallurgy | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.